Previous studies revealed that IL-6, TGF-β stromal cell-derived factor 1 (SDF-1), RANKL, and CCL2 produced by bone stromal and tumor cells are responsible for this alteration in the attacked bone tissue (56–59). Here, IL6 is linked to neoplasm.